Evidence map›Paper›PMID 34497286›Full record

ArticleScientific reports2021

Publisher Correction: Age-dependent ataxia and neurodegeneration caused by an αII spectrin mutation with impaired regulation of its calpain sensitivity.

Arkadiusz Miazek, Michał Zalas, Joanna Skrzymowska, Bryan A Bogin, Krzysztof Grzymajło, Tomasz M Goszczynski, Zachary A Levine, Jon S Morrow, Michael C Stankewich

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Arkadiusz MiazekDepartment of Tumor Immunology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53‑114, Wrocław, Poland.
Michał ZalasDepartment of Tumor Immunology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53‑114, Wrocław, Poland.
Joanna SkrzymowskaDepartment of Tumor Immunology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53‑114, Wrocław, Poland.
Bryan A BoginDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.
Krzysztof GrzymajłoDepartment of Biochemistry and Molecular Biology, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50‑375, Wrocław, Poland.
Tomasz M GoszczynskiDepartment of Tumor Immunology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53‑114, Wrocław, Poland.
Zachary A LevineDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.
Jon S MorrowDepartment of Pathology, Yale University School of Medicine, 310 Cedar Street, LH108, New Haven, CT, 06520, USA. jon.morrow@yale.edu.
Michael C StankewichDepartment of Pathology, Yale University School of Medicine, 310 Cedar Street, LH108, New Haven, CT, 06520, USA. michael.stankewich@yale.edu.
Yale University · USLudwik Hirszfeld Institute of Immunology and Experimental Therapy · PLPolish Academy of Sciences · PLWroclaw University of Environmental and Life Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34497286
PMCPMC8426364
OpenAlexW3198547462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.